| For: | Honda S, Sawada K, Hasebe T, Nakajima S, Fujiya M, Okumura T. Tegafur-uracil-induced rapid development of advanced hepatic fibrosis. World J Gastroenterol 2017; 23(31): 5823-5828 [PMID: 28883709 DOI: 10.3748/wjg.v23.i31.5823] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i31/5823.htm |
| Number | Citing Articles |
| 1 |
Hong Shao, Wen Li, Zhuohan Li, Peng Shi, Zheng Li, Yuxiang Wang, Chao Pi, Lingmao Zhao, Wenwu Zheng, Yumeng Wei, Ling Zhao. Construction of in situ temperature-sensitive gel of Tegafur derivative TAK5399 and its evaluation against breast cancer. European Journal of Pharmaceutical Sciences 2026; 218: 107452 doi: 10.1016/j.ejps.2026.107452
|
| 2 |
Mark Real, Michele S. Barnhill, Cory Higley, Jessica Rosenberg, James H. Lewis. Drug-Induced Liver Injury: Highlights of the Recent Literature. Drug Safety 2019; 42(3): 365 doi: 10.1007/s40264-018-0743-2
|
| 3 |
Jiaguang Song, Yuezhong Zhang, Jinling Cheng, Shi Wang, Zhi Liu, Dianmin Sun. Non-invasive quantitative diagnosis of liver fibrosis with an artificial neural network. Neural Computing and Applications 2022; 34(9): 6733 doi: 10.1007/s00521-021-06257-3
|
| 4 |
Azar Zochedh, Kaliraj Chandran, Athimoolam Shunmuganarayanan, Asath Bahadur Sultan. Exploring the Synergistic Effect of Tegafur-Syringic Acid Adduct Against Breast Cancer through DFT Computation, Spectroscopy, Pharmacokinetics and Molecular Docking Simulation. Polycyclic Aromatic Compounds 2024; 44(4): 2153 doi: 10.1080/10406638.2023.2214281
|
| 5 |
|
| 6 |
Naoki Yoshida, Atsushi Kanno, Atsushi Masamune, Tatsuhide Nabeshima, Seiji Hongo, Shin Miura, Tetsuya Takikawa, Shin Hamada, Kazuhiro Kikuta, Kiyoshi Kume, Masamichi Ueno, Tooru Shimosegawa. Pancreatic Acinar Cell Carcinoma with Multiple Liver Metastases Effectively Treated by S-1 Chemotherapy. Internal Medicine 2018; 57(24): 3529 doi: 10.2169/internalmedicine.0294-17
|
